Sphygmomanometer Market

Sphygmomanometer Market Poised Due to Advancements in Wireless Blood Pressure Monitoring Technology


Sphygmomanometers, commonly known as blood pressure monitors, are medical devices used to measure blood pressure non-invasively. They consist of an inflatable cuff wrapped around the arm and a mercury or mechanical manometer to measure arterial pressure in mmHg. Blood pressure monitors help in early detection of hypertension and monitoring of blood pressure levels in patients with cardiovascular diseases. Wireless connectivity and smartphone compatibility in modern sphygmomanometers have made self-monitoring of blood pressure more convenient. The growing elderly population, increasing awareness about hypertension, and technological advancements in blood pressure monitoring devices are fueling demand for sphygmomanometers globally.

The Global Sphygmomanometer Market is estimated to be valued at US$ 3.92 Bn in 2024 and is expected to exhibit a CAGR of 9.1% over the forecast period 2024 to 2031.

Key Takeaways:

Key players operating in the Sphygmomanometer market are Omron Healthcare, ICU Medical Inc., Koninklijke Philips N.V., Baxter, Nihon Kohden, A&D Medical, Spengler, SunTech Medical, Rudolf Riester GmbH, Microlife Corporation, American Diagnostic Corporation, Panasonic Healthcare, Beurer, Rossmax International Ltd., PAUL HARTMANN, BPL Medical Technologies, Homedics.

The key opportunities in the Sphygmomanometer Market Demand include increasing awareness about home monitoring of hypertension through digital health campaigns and growing healthcare expenditures in emerging economies.

Technological advancements like integration of Bluetooth and Wi-Fi in sphygmomanometers are enabling wireless transmission of readings to mobile devices and easy sharing with physicians. Automated oscillometric technology provides accurate and reliable measurements.

Market Drivers:

The main drivers of sphygmomanometer market growth are aging population and rising prevalence of hypertension globally. As per WHO, hypertension currently affects over 1.13 billion people worldwide. Growing health consciousness and dominance of self-monitoring devices are also propelling the demand for home-use blood pressure monitoring devices. Favorable health reimbursement policies for chronic disease management further support the market expansion.

Current Challenges in Sphygmomanometer Market

Emerging economies are witnessing a rise in demand for remote patient monitoring systems and home healthcare devices, however infrastructure limitations pose significant challenges. Lack of skilled medical professionals and uneven healthcare access across regions can restrict market growth. Additionally, the high costs associated with advanced automated blood pressure monitoring devices makes it inaccessible for large population segments in developing nations. Players must focus on manufacturing affordable and easy-to-use sphygmomanometers to cater to global demand.

SWOT Analysis

Strength: Accuracy and reliability in blood pressure readings. Wide usage in hospitals, clinics, and personal healthcare.

Weakness: Mercury sphygmomanometers require trained professionals. Automated devices have high upfront costs.

Opportunity: Growing elderly population and rising lifestyle diseases drive market potential. Investments in remote monitoring and telehealth present new avenues.

Threats: Economic slowdowns can decrease healthcare budgets and expenditures. Alternative diagnostic methods pose competition.

North America is currently the leading regional market for sphygmomanometers and holds around 35% of the global value share. This is attributable to well-developed healthcare infrastructure, rising prevalence of cardiovascular diseases, and growing preference for home monitoring devices. Asia Pacific is projected to witness the fastest growth during the forecast period owing to rising healthcare spending, rapid urbanization, evolving lifestyles, and increasing focus on preventive healthcare in populous nations such as India and China.

In terms of value, the concentrated markets for sphygmomanometers are currently North America, Western Europe, and Japan. However, Asia Pacific is emerging as the fastest growing regional market due to improving access to healthcare services, growing middle class demographic, and expansion of private healthcare facilities in developing Asian countries.

1.  Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it